Dr. Johnson is a prolific entrepreneur, having started seven successful life sciences businesses, and he is the author of several publications and patents. Dr. Johnson is currently the head of Hudson Global, a portfolio of pharmaceutical service companies, including Hudson Medical Communications a medical marketing company, Hudson Biosciences, a phase IV CRO, and Axiom, a continuing medical education provider. He also is the founder of AlveoLogic, a dental device company. Dr. Johnson co-founded QED communications, which was acquired by Quintiles Transnational, and he most recently held the position of CEO of Vertos Medical, Inc. where he successfully closed series C round of funding.
Previously, Dr. Johnson was the CEO of Quintiles Commercialization North America, a group of Quintiles subsidiaries that had combined revenues of over $400 million. In 2003, Dr. Johnson led a bid to attempt to privatize Quintiles for $1.8 billion. Dr. Johnson’s experience also includes senior positions at Lederle Laboratories, a Fortune 500 pharmaceutical company. Dr. Johnson earned a bachelor’s degree (Phi Beta Kappa) from New York University and a medical degree from Mount Sinai School of Medicine. He received graduate business training from Columbia University’s Executive Management Training Program. “Dr. Johnson brings a wealth of experience to Clinilabs and we look forward to the great contributions that he will undoubtedly make to our organization.” states Dr. Gary Zammit, President and CEO of Clinilabs.
About Clinilabs Inc.
Clinilabs is a contract research organization (CRO) that provides early-phase and specialty clinical drug development services to industry. We offer teams, processes, and technology solutions that are designed to serve single center and multicenter early-phase studies – services that can be scaled as needed to meet the requirements of any clinical development program. For more information, please visit www.clinilabs.com.
For more information or to schedule an interview, please contact Jeanine Estrada at 646.450.2215 or e-mail jestrada@clinilabs.com.
